Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status

Neuropsychologia

Volumn 75, Issue , 2015, Pages 411-419

  Albrecht, Matthew A ^a,b   Szoeke, Cassandra ^c,d   Maruff, Paul ^e   Savage, Greg ^f   Lautenschlager, Nicola T ^g,h   Ellis, Kathryn A ^c,g   Taddei, Kevin ^i,j   Martins, Ralph ^i,j   Masters, Colin L ^g   Ames, David ^c,g   Foster, Jonathan K ^a,k  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d CSIRO   (Australia)

^e Scientific Division   (Australia)

^f MACQUARIE UNIVERSITY   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ EDITH COWAN UNIVERSITY   (Australia)

^j HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^k Neurosciences Unit   (Australia)

more..

Author keywords

Ageing; Alzheimer's disease; Apolipoprotein 4; Bayesian; Longitudinal; Mild cognitive impairment; Neuropsychological performance

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ALLELE; APOE GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISODIC MEMORY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MENTAL HEALTH; MENTAL TASK; MILD COGNITIVE IMPAIRMENT; COGNITIVE AGING; GENETICS; NEUROPSYCHOLOGICAL TEST;

AGED; APOLIPOPROTEIN E4; COGNITIVE AGING; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84935095980     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2015.06.008     Document Type: Article

References (51)

1. Albert M., Moss M.B., Blacker D., Tanzi R., McArdle J.J. Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology 2007, 21:158-169.
2. Amieva H., Le Goff M., Millet X., Orgogozo J.M., Pérès K., Barberger-Gateau P., Jacqmin-Gadda H., Dartigues J.F. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann. Neurol. 2008, 64:492-498.
3. Bretsky P., Guralnik J.M., Launer L., Albert M., Seeman T.E. The role of APOE ε4 in longitudinal cognitive decline. Neurology 2003, 60:1077-1081.
4. Caselli R.J., Dueck A.C., Locke D.E.C., Hoffman-Snyder C.R., Woodruff B.K., Rapcsak S.Z., Reiman E.M. Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers. Neurology 2011, 76:1383-1388.
5. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., Baxter L.C., Rapcsak S.Z., Shi J., Woodruff B.K., Locke D.E.C., Snyder C.H., Alexander G.E., Rademakers R., Reiman E.M. Longitudinal modeling of age-related memory decline and the APOE ε4 effect. N. Engl. J. Med. 2009, 361:255-263.
6. Caselli R.J., Reiman E., Osborne D., Hentz J., Baxter L., Hernandez J., Alexander G. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004, 62:1990-1995.
7. Caselli R., Reiman E., Locke D., Hutton M.L., Hentz J., Hoffman-Snyder C., Woodruff B.K., Alexander G., Osborne D. Cognitive domain decline in healthy apolipoprotein e ε4 homozygotes before the diagnosis of mild cognitive impairment. Arch. Neurol. 2007, 64:1306-1311.
8. Christensen H., Batterham P.J., Mackinnon A.J., Jorm A.F., Mack H.A., Mather K.A., Anstey K.J., Sachdev P.S., Easteal S. The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatr. 2008, 8:14.
9. Collie A., Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci. Biobehav. Rev. 2000, 24:365-374.
10. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
11. Elias M.F., Beiser A., Wolf P.A., Au R., White R.F., D'Agostino R.B. The preclinical phase of Alzheimer disease: a 22-year prospective study of the framingham cohort. Arch. Neurol. 2000, 57:808-813.
12. Ellis K.A., Bush A.I., Darby D., De Fazio D., Foster J., Hudson P., Lautenschlager N.T., Lenzo N., Martins R.N., Maruff P. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int. Psychogeriatr. 2009, 21:672-687.
13. Floel A., Poeppel D., Buffalo E.A., Braun A., Wu C.W.-H., Seo H.-J., et al. Prefrontal cortex asymmetry for memory encoding of words and abstract shapes. Cereb. Cortex 2004, 14:404-409.
14. Foster J.K., Albrecht M.A., Savage G., Lautenschlager N.T., Ellis K.A., Maruff P., Szoeke C., Taddei K., Martins R., Masters C.L., Ames D. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain 2013, 136:2201-2216.
15. Gelman A., Hill J. Data Analysis Using Regression and Multilevel/Hierarchical Models 2007, Cambridge University Press, New York, (accessed July 6.07.12).
16. Gelman A., Hill J., Yajima M. Why we (usually) don't have to worry about multiple comparisons. J. Res. Educ. Eff. 2012, 5:189-211.
17. Gelman A., Rubin D.B. Inference from iterative simulation using multiple sequences. Stat. Sci. 1992, 7:457-472.
18. Jack C.R., Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., Shiung M.M., Gunter J.L., Boeve B.F., Kemp B.J., Weiner M., Petersen R.C. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
19. Kruschke J.K. Doing Bayesian Data Analysis: A tutorial with R and BUGS 2011, Academic Press Elsevier, Burlington USA, (accessed 6.07.12).
20. Kruschke J.K. Bayesian estimation supersedes the t test. J. Exp. Psychol.: Gen. 2013, 142:573-603.
21. Lam V., Albrecht M.A., Takechi R., Giles C., James A.P., Foster J.K., Mamo J.C.L. The serum concentration of the calcium binding protein S100B is positively associated with cognitive performance in older adults. Front. Aging Neurosci. 2013, 5:61.
22. Lange K.L., Little R.J.A., Taylor J.M.G. Robust statistical modeling using the t distribution. J. Am. Stat. Assoc. 1989, 84:881-896.
23. Lezak M.D., Howieson D.B., Bigler E.D., Tranel D. Neuropsychological Assessment 2012, Oxford University Press, Oxford, UK. fifth edition.
24. Lim Y.Y., Ellis K.A., Pietrzak R.H., Ames D., Darby D., Harrington K., Martins R.N., Masters C.L., Rowe C., Savage G., Szoeke C., Villemagne V.L., Maruff P. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology 2012, 79:1645-1652.
25. Lim Y.Y., Villemagne V.L., Pietrzak R.H., Ames D., Ellis K.A., Harrington K., Snyder P.J., Martins R.N., Masters C.L., Rowe C.C., Maruff P. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiol. Aging 2015, 36:1239-1244.
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
27. Milner B., Corsi P., Leonard G. Frontal-lobe contribution to recency judgements. Neuropsychologia 1991, 29:601-618.
28. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Kokmen E., Tangelos E.G. Aging, memory, and mild cognitive impairment. Int. Psychogeriatr. 1997, 9:65-69.
29. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303.
30. Pike K.E., Ellis K.A., Villemagne V.L., Good N., Chételat G., Ames D., Szoeke C., Laws S.M., Verdile G., Martins R.N., Masters C.L., Rowe C.C. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia 2011, 49:2384-2390.
31. PlummerM (2003) JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. In: Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003). March, pp. 20-22. Available at: (accessed 6.07.12). http://www.ci.tuwien.ac.at/Conferences/DSC-2003/Drafts/Plummer.pdf.
32. PlummerM (2011) rjags: Bayesian graphical models using MCMC. Available at: . http://CRAN.R-project.org/package=rjags.
33. Prendergast G., Limbrick-Oldfield E., Ingamells E., Gathercole S., Baddeley A., Green G.G.R. Differential patterns of prefrontal meg activation during verbal & visual encoding and retrieval. PLoS One 2013, 8:e82936.
34. R Development Core Team R: A Language and Environment for Statistical Computing 2012, R Foundation for Statistical Computing., Vienna, Austria, Available at.
35. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B.S., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., DeKosky S.T., Caselli R.J. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2009, 106:6820-6825.
36. Riley M.W. Aging and cohort succession: interpretations and misinterpretations. Public Opin. Q. 1973, 37:35.
37. Rowe C.C., et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol. Aging 2010, 31:1275-1283.
38. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele Ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467.
39. Schaie K.W. When does age-related cognitive decline begin? Salthouse again reifies the 'cross-sectional fallacy'. Neurobiol. Aging 2009, 30:528-533.
40. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 1993, 90:1977-1981.
41. Strauss E., Sherman E.M.S., Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary 2006, third edition.
42. Tanner M.A., Wong W.H. The calculation of posterior distributions by data augmentation. J. Am. Stat. Assoc. 1987, 82:528-540.
43. Thurston S.W., Ruppert D., Davidson P.W. Bayesian models for multiple outcomes nested in domains. Biometrics 2009, 65:1078-1086.
44. Tobin J. Estimation of relationships for limited dependent variables. J. Econom. Soc. 1958, 24-36.
45. Villain N., Chételat G., Grassiot B., Bourgeat P., Jones G., Ellis K.A., Ames D., Martins R.N., Eustache F., Salvado O., Masters C.L., Rowe C.C., Villemagne V.L. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain 2012, 135:2126-2139.
46. Villemagne V.L., Burnham S., Bourgeat P., Brown B., Ellis K.A., Salvado O., Szoeke C., Macaulay S.L., Martins R., Maruff P., Ames D., Rowe C.C., Masters C.L. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013, 12:357-367.
47. Wang L., Zhang Z., McArdle J.J., Salthouse T.A. Investigating ceiling effects in longitudinal data analysis. Multivar. Behav. Res. 2009, 43:476-496.
48. Wilson R.S., Schneider J.A., Barnes L.L., Beckett L.A., Aggarwal N.T., Cochran E.J., Berry-Kravis E., Bach J., Fox J.H., Evans D.A., Bennett D.A. The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 2002, 59:1154-1160.
49. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Bäckman L., Albert M., Almkvist O. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004, 256:240-246.
50. Winnock M., Letenneur L., Jacqmin-Gadda H., Dallongeville J., Amouyel P., Dartigues J. Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study. J. Neurol. Neurosurg. Psychiatry 2002, 72:794-797.
51. Wisdom N.M., Callahan J.L., Hawkins K.A. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 2011, 32:63-74.